Zero diagnostic yield of dysplasia in polyp adjacent biopsies for patients with inflammatory bowel disease

Zero diagnostic yield of dysplasia in polyp adjacent biopsies for patients with inflammatory bowel disease

Bibliographic Details
Main Authors:	Lahiff, C, Wang, L, Travis, S, East, J
Format:	Conference item
Published:	Oxford University Press 2017

Similar Items

Diagnostic yield of diagnostic yield of polyp-adjacent biopsies for patients with inflammatory bowel disease: A cross-sectional study
by: Lahiff, C, et al.
Published: (2018)

Polyp-adjacent biopsies no longer required in inflammatory bowel disease
by: Lahiff, C, et al.
Published: (2018)

Endoscopic submucosal dissection for nonpolypoid colorectal dysplasia in patients with inflammatory bowel disease: in medias res
by: Soetikno, R, et al.
Published: (2018)

Endoscopic approach to polyp recognition
by: Lahiff, C, et al.
Published: (2017)

Surveillance of patients with inflammatory bowel disease
by: Yu, J, et al.
Published: (2016)

Salicylates for inflammatory bowel disease.
by: Travis, S, et al.
Published: (1994)

Patient-reported goals in inflammatory bowel disease: what’s the problem?
by: Wong, D, et al.
Published: (2021)

Strategies for detecting colon cancer in patients with inflammatory bowel disease
by: Bye, W, et al.
Published: (2017)

The diagnostic approach to monogenic very early onset inflammatory bowel disease
by: Uhlig, H, et al.
Published: (2014)

Osteoporosis in patients with inflammatory bowel disease.
by: Arden, N, et al.
Published: (2002)

Improving the quality of care for inflammatory bowel disease
by: Ye, B, et al.
Published: (2018)

Conventional medical management of inflammatory bowel disease.
by: Burger, D, et al.
Published: (2011)

Conventional drug therapy for inflammatory bowel disease.
by: Bryant, R, et al.
Published: (2015)

Guidelines for the management of inflammatory bowel disease in adults.
by: Carter, M, et al.
Published: (2004)

Jejunojejunal intussusception secondary to inflammatory fibroid polyp: A rare cause of small bowel obstruction
by: Jun Sam Tan, et al.
Published: (2020)

Prevalence of inflammatory bowel disease in patients with airways disease.
by: Raj, A, et al.
Published: (2008)

Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials
by: Ahmad, HA, et al.
Published: (2023)

Patient reported outcome measures (PROMs) in inflammatory bowel disease: new data
by: Bojic, D, et al.
Published: (2016)

Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
by: Bansi, D, et al.
Published: (1996)

Central Endoscopy Reading in Inflammatory Bowel Diseases
by: Panés, J, et al.
Published: (2016)

What is the optimal treatment for anemia in inflammatory bowel disease?
by: Kent, A, et al.
Published: (2012)

Letter: inflammatory bowel disease guidelines and conflicts of interest.
by: Eliakim, R, et al.
Published: (2013)

Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease
by: Travis, S, et al.
Published: (2018)

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions
by: Ahmad, HA, et al.
Published: (2023)

Consequences of identifying XIAP deficiency in an adult patient with inflammatory bowel disease
by: Quaranta, M, et al.
Published: (2018)

Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model
by: Han, Qiyuan, et al.
Published: (2021)

Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model
by: Han, Qiyuan, et al.
Published: (2022)

Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model
by: Han, Qiyuan, et al.
Published: (2021)

Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model
by: Han, Qiyuan, et al.
Published: (2022)

Mucosal healing in inflammatory bowel diseases: a systematic review.
by: Neurath, M, et al.
Published: (2012)

What's app? Electronic health technology in inflammatory bowel disease
by: Walsh, A, et al.
Published: (2018)

Prevalence of osteoporosis in Malaysian patients with inflammatory bowel disease
by: Hilmi, S.I., et al.
Published: (2010)

Alpha 2-macroglobulin in patients with inflammatory bowel disease.
by: Brown, D, et al.
Published: (1980)

Splenic phagocytic function in patients with inflammatory bowel disease.
by: Jewell, D, et al.
Published: (1981)

Adult intussusception secondary to inflammatory polyps
by: Jabar, Mohd Faisal, et al.
Published: (2005)

Atopy in inflammatory bowel disease.
by: Mee, A, et al.
Published: (1979)

Genetics of inflammatory bowel disease.
by: Satsangi, J, et al.
Published: (1998)

Immunology of inflammatory bowel disease.
by: Jewell, D, et al.
Published: (1985)

The genetics of inflammatory bowel disease.
by: Satsangi, J, et al.
Published: (1997)

Genetics of inflammatory bowel disease.
by: Satsangi, J, et al.
Published: (1994)